We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.33%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$107B
AUM Growth
-$4.74B
Cap. Flow
-$4.5B
Cap. Flow %
-4.19%
Top 10 Hldgs %
16.64%
Holding
4,289
New
314
Increased
1,937
Reduced
1,469
Closed
342

Sector Composition

Rank Sector Weight
1 Technology 12.27%
2 Financials 11.39%
3 Healthcare 9.26%
4 Consumer Discretionary 6.73%
5 Industrials 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VBIV
3726
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$56K ﹤0.01%
+534
New +$63.7K
AVID
3727
DELISTED
Avid Technology Inc
AVID
$54K ﹤0.01%
12,068
-2,981
-20% -$15.1K
RLGT icon
3728
Radiant Logistics
RLGT
$386M
$53K ﹤0.01%
13,855
+3,199
+30% +$13.6K
QTNT
3729
DELISTED
Quotient Limited Ordinary Shares
QTNT
$53K ﹤0.01%
+278
New +$50.1K
ALTO icon
3730
Alto Ingredients
ALTO
$369M
$52K ﹤0.01%
17,239
+4,263
+33% +$17K
III icon
3731
Information Services Group
III
$199M
$52K ﹤0.01%
+12,443
New +$52.3K
CVRS
3732
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$52K ﹤0.01%
37,851
+8,683
+30% +$10.1K
OSG
3733
DELISTED
Overseas Shipholding Group Inc.
OSG
$51K ﹤0.01%
17,737
+3,658
+26% +$8.52K
FGP
3734
DELISTED
Ferrellgas Partners, L.P.
FGP
$51K ﹤0.01%
16,077
-20,894
-57% -$81.3K
SIOX
3735
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$50K ﹤0.01%
4,658
+118
+3% +$1.9K
MEET
3736
DELISTED
The Meet Group, Inc. Common Stock
MEET
$50K ﹤0.01%
23,770
+3,999
+20% +$10.4K
FENG
3737
Phoenix New Media
FENG
$18.3M
$49K ﹤0.01%
+1,861
New +$64.8K
NYMX
3738
DELISTED
Nymox Pharmaceutical Corp
NYMX
$49K ﹤0.01%
+11,672
New +$40.5K
ICD
3739
DELISTED
Independence Contract Drilling, Inc.
ICD
$48K ﹤0.01%
633
+67
+12% +$5.88K
AVEO
3740
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$48K ﹤0.01%
1,647
-885
-35% -$25.9K
SHLD
3741
DELISTED
Sears Holding Corporation
SHLD
$46K ﹤0.01%
17,193
-237,168
-93% -$641K
GST
3742
DELISTED
Gastar Exploration Inc.
GST
$46K ﹤0.01%
67,299
+15,508
+30% +$14.5K
AUY
3743
PUT
DELISTED
Yamana Gold, Inc.
AUY
$45K ﹤0.01%
16,400
-10,400
-39% -$32.1K
HIVE
3744
DELISTED
Aerohive Networks
HIVE
$45K ﹤0.01%
+11,170
New +$50.2K
EGC
3745
DELISTED
Energy XXI Gulf Coast, Inc. Common Stock
EGC
$45K ﹤0.01%
11,783
-6,713
-36% -$39K
OTIC
3746
DELISTED
Otonomy, Inc.
OTIC
$44K ﹤0.01%
+10,789
New +$58.8K
ASXC
3747
DELISTED
Asensus Surgical, Inc.
ASXC
$43K ﹤0.01%
+1,938
New +$44.3K
CTIC
3748
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$43K ﹤0.01%
+11,090
New +$39K
FRED
3749
DELISTED
Fred's Inc
FRED
$42K ﹤0.01%
13,899
+2,732
+24% +$9.06K
AMRN
3750
Amarin Corp
AMRN
$299M
$41K ﹤0.01%
681
-110
-14% -$8.17K

Similar funds

Credit Suisse's Q1 2018 Portfolio in Review

As of Q1 2018, Credit Suisse held 4,289 positions worth $107B, down 4.2% from $112B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse withdrew a net $4.5B in Q1 2018, closing 342 positions and reducing 1,469 holdings. Its most notable exit was VelocityShares Daily Inverse VIX Short Term ETN, an estimated $959M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Credit Suisse opened a new position in Cambria Shareholder Yield ETF worth $75.4M.

  • Credit Suisse's largest Q1 2018 buy was Cambria Shareholder Yield ETF: 2,000,000 shares worth $75.4M.
  • Credit Suisse added most to iShares Core S&P Mid-Cap ETF in Q1 2018, an estimated $731M increase.
  • Credit Suisse's biggest Q1 2018 reduction was UnitedHealth, cutting an estimated $1.54B.
  • Credit Suisse fully exited VelocityShares Daily Inverse VIX Short Term ETN in Q1 2018, selling an estimated $959M.
  • Credit Suisse's ten largest holdings make up 17% of its $107B portfolio in Q1 2018.
  • Credit Suisse opened 314 new positions and closed 342 in Q1 2018.
  • Credit Suisse's portfolio value fell 4.2% quarter-over-quarter to $107B.

Based on Credit Suisse's 13F filing for Q1 2018, filed 15 May 2018.